News

SELLAS Nears Key AML Data: Insights for Investors and BD Teams

acute myeloid leukemia · 2 min

Top 10 Biopharma M&A Deals of 2025: Market Analysis

4 min

FDA Approves Atezolizumab for Muscle-Invasive Bladder Cancer

FDA · oncology · 3 min

M&A in Pharmaceuticals: Bigger, Bolder, and Far More Strategic

2 min

Big Pharma M&A Set for Mega Year Amid Patent Expiries

4 min

UCB Acquires Antibody Treatment Maker: Implications for Autoimmune Disease Market

autoimmune disease · 3 min

Regulatory Round-Up: Key FDA Approvals for Cancer Drugs

FDA · cancer · 3 min

FDA Leadership Changes Crisis: Implications for Drug Approvals

FDA · 3 min

10 Clinical Trials to Watch in the First Half of 2026

4 min

Pharma M&A Round-Up: April 2026 Insights and Analysis

2 min

Makary Resigns as FDA Commissioner: Implications for Drug Approvals

FDA · 3 min

FDA Roundup: Oncology Drug Approvals in 2026

FDA · oncology · 3 min